Sort   by:  
 Page size 
MetabolomicsA next-generation yeast chassis: comprehensive characterization of a robust fast-growing Saccharomyces cerevisiae

Robust and efficient hosts are necessary to facilitate advances in biotechnology. We unveil Saccharomyces cerevisiae strain XP as a promising new microbial chassis owing to its high growth rate and robustness. This strain has a doubling time of 48.2 min, which is 12.8 min faster than the...

2024-09-26 | MTBLS7328 | MetaboLights
UnknownRisk factors analysis for percutaneous endoscopic gastrostomy in patients with oral cancer: a retrospective study.
Not available
S-EPMC12268388 | biostudies-literature
UnknownPeriodontitis exacerbates pulmonary hypertension by promoting IFNγ<sup>+</sup> T cell infiltration in mice.
Not available
S-EPMC10978940 | biostudies-literature
UnknownIdentification and Characterization of CD8+ CD27+ CXCR3- T Cell Dysregulation and Progression-Associated Biomarkers in Systemic Lupus Erythematosus.
Not available
S-EPMC10724430 | biostudies-literature
UnknownAtomically Dispersed Iron Active Sites Promoting Reversible Redox Kinetics and Suppressing Shuttle Effect in Aluminum-Sulfur Batteries.
Not available
S-EPMC9392677 | biostudies-literature
UnknownTargeting Wnt Signaling in the Tumor Immune Microenvironment to Enhancing EpCAM CAR T-Cell therapy.
Not available
S-EPMC8591126 | biostudies-literature
UnknownIdentification of COVID-19 severity biomarkers based on feature selection on single-cell RNA-Seq data of CD8+ T cells.
Not available
S-EPMC9682094 | biostudies-literature
UnknownDNA-PK-mediated phosphorylation of EZH2 regulates the DNA damage-induced apoptosis to maintain T-cell genomic integrity.
Not available
S-EPMC4973345 | biostudies-literature
UnknownPPE38 Protein of Mycobacterium tuberculosis Inhibits Macrophage MHC Class I Expression and Dampens CD8+ T Cell Responses.
Not available
S-EPMC5346565 | biostudies-literature
MetabolomicsMethionine Intervention Induces PD-L1 Expression to Enhance the Immune Checkpoint Therapy Response in MTAP-deleted Osteosarcoma
Osteosarcoma (OS), a malignant bone tumor with limited treatment options, exhibits low sensitivity to immune checkpoint therapy (ICT). Through genomics and transcriptomics analyses, we have identified a subgroup of OS with methylthioadenosine phosphorylase (MTAP) deletion, which contributes to ICT r...
2026-06-09 | MTBLS11985 | MetaboLights
Sort   by:  
 Page size